Xiamen Historical Cash Flow
| 688278 Stock | 73.51 0.41 0.56% |
Analysis of Xiamen Amoytop cash flow over time is an excellent tool to project Xiamen Amoytop Biotech future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 42 M or Dividends Paid of 104.6 M as it is a great indicator of Xiamen Amoytop ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Xiamen Amoytop Biotech latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Xiamen Amoytop Biotech is a good buy for the upcoming year.
Xiamen |
About Xiamen Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Xiamen balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Xiamen's non-liquid assets can be easily converted into cash.
Xiamen Amoytop Cash Flow Chart
Add Fundamental
Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Capital Expenditures
Capital Expenditures are funds used by Xiamen Amoytop Biotech to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Xiamen Amoytop operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Xiamen Amoytop Biotech financial statement analysis. It represents the amount of money remaining after all of Xiamen Amoytop Biotech operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most accounts from Xiamen Amoytop's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Xiamen Amoytop Biotech current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Xiamen Amoytop Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At present, Xiamen Amoytop's Change In Cash is projected to increase significantly based on the last few years of reporting. The current year's Dividends Paid is expected to grow to about 104.6 M, whereas Change To Inventory is projected to grow to (49 M).
| 2022 | 2023 | 2024 | 2025 (projected) | Dividends Paid | 40.7M | 86.6M | 99.6M | 104.6M | Depreciation | 48.1M | 58.7M | 67.5M | 42.0M |
Xiamen Amoytop cash flow statement Correlations
Click cells to compare fundamentals
Xiamen Amoytop Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Xiamen Amoytop cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (29.0M) | (16.9M) | (13.2M) | (57.3M) | (51.6M) | (49.0M) | |
| Change In Cash | (9.2M) | 88.3M | 15.4M | 189.5M | 217.9M | 228.8M | |
| Total Cashflows From Investing Activities | (14.5M) | (44.7M) | (382.0M) | (111.8M) | (100.7M) | (105.7M) | |
| Depreciation | 38.2M | 42.2M | 48.1M | 58.7M | 67.5M | 42.0M | |
| Dividends Paid | 12.7M | 20.7M | 40.7M | 86.6M | 99.6M | 104.6M | |
| Capital Expenditures | 118.8M | 190.9M | 219.2M | 244.5M | 281.2M | 295.2M | |
| Total Cash From Operating Activities | 92.6M | 234.8M | 363.2M | 512.1M | 588.9M | 618.4M | |
| Net Income | 116.6M | 181.2M | 287.0M | 554.3M | 637.5M | 669.4M | |
| End Period Cash Flow | 196.7M | 284.9M | 300.3M | 526.5M | 605.4M | 635.7M | |
| Change To Netincome | 1.9M | 5.8M | (1.1M) | (5.7M) | (5.2M) | (4.9M) | |
| Free Cash Flow | (26.2M) | 43.9M | 144.0M | 274.9M | 316.1M | 331.9M | |
| Change In Working Capital | (61.8M) | 15.0M | 30.5M | (121.1M) | (109.0M) | (103.5M) | |
| Begin Period Cash Flow | 205.9M | 196.7M | 284.9M | 335.4M | 385.7M | 217.9M | |
| Other Non Cash Items | 4.1M | 2.7M | 2.9M | 11.1M | 12.8M | 13.4M | |
| Change To Account Receivables | (1.1M) | 9.1M | (42.4M) | (24.5M) | (22.1M) | (23.2M) | |
| Total Cash From Financing Activities | (13.8M) | (17.9M) | 281.1M | (34.2M) | (39.3M) | (37.4M) |
Currently Active Assets on Macroaxis
Other Information on Investing in Xiamen Stock
The Cash Flow Statement is a financial statement that shows how changes in Xiamen balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Xiamen's non-liquid assets can be easily converted into cash.